| 2026-02-06 |
详情>>
内部人交易：
DeLuca Richard R.等共交易4笔
|
| 2026-02-03 |
详情>>
业绩披露：
2025年年报每股收益7.35美元,归母净利润182.54亿美元,同比去年增长6.64%
|
| 2026-02-03 |
财报披露：
美东时间 2026-02-03 盘前发布财报
|
| 2025-11-05 |
详情>>
股本变动：
变动后总股本248202.25万股
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益6.09美元,归母净利润152.91亿美元,同比去年增长14.33%
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益3.78美元,归母净利润95.06亿美元,同比去年增长-6.96%
|
| 2025-05-02 |
详情>>
业绩披露：
2025年一季报每股收益2.01美元,归母净利润50.79亿美元,同比去年增长6.66%
|
| 2025-04-09 |
股东大会：
将于2025-05-27召开股东大会
会议内容 ▼▲
- 1.Elect the 13 Director nominees named in this proxy statement;
2.Consider and act upon a proposal to approve, by non-binding advisory vote, the compensation of our Named Executive Officers;
3.Consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2025;
4.Consider and act upon a shareholder proposal regarding a human rights impact assessment, if properly presented at the meeting;
5.Consider and act upon a shareholder proposal regarding a tax transparency report, if properly presented at the meeting;
6.Consider and act upon a shareholder proposal to revisit DEI goals in executive pay incentives, if properly presented at the meeting;
7.Consider and act upon a shareholder proposal regarding a report on civil liberties in advertising services, if properly presented at the meeting;
8.Transact such other business as may properly come before the meeting.
|
| 2025-04-09 |
股东大会：
将于2025-05-27召开股东大会
会议内容 ▼▲
- 1.Elect the 13 Director nominees named in this proxy statement;
2.Consider and act upon a proposal to approve, by non-binding advisory vote, the compensation of our Named Executive Officers;
3.Consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2025;
4.Consider and act upon a shareholder proposal regarding a human rights impact assessment, if properly presented at the meeting;
5.Consider and act upon a shareholder proposal regarding a tax transparency report, if properly presented at the meeting;
6.Consider and act upon a shareholder proposal to revisit DEI goals in executive pay incentives, if properly presented at the meeting;
7.Consider and act upon a shareholder proposal regarding a report on civil liberties in advertising services, if properly presented at the meeting;
8.Transact such other business as may properly come before the meeting.
|
| 2025-02-25 |
详情>>
业绩披露：
2022年年报每股收益5.73美元,归母净利润145.19亿美元,同比去年增长11.27%
|
| 2025-02-25 |
详情>>
业绩披露：
2024年年报每股收益6.76美元,归母净利润171.17亿美元,同比去年增长4589.59%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益5.28美元,归母净利润133.74亿美元,同比去年增长740.60%
|
| 2024-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.63美元,归母净利润15.91亿美元,同比去年增长-86.17%
|
| 2024-08-05 |
详情>>
业绩披露：
2024年中报每股收益4.03美元,归母净利润102.17亿美元,同比去年增长423.94%
|
| 2024-05-03 |
详情>>
业绩披露：
2024年一季报每股收益1.88美元,归母净利润47.62亿美元,同比去年增长68.81%
|
| 2024-04-11 |
股东大会：
将于2024-05-28召开股东大会
会议内容 ▼▲
- 1.Elect the 12 Director nominees named in this proxy statement;
2.Consider and act upon a proposal to approve, by non-binding advisory vote, the compensation of our Named Executive Officers;
3.Consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2024;
4. Consider and act upon a shareholder proposal regarding a shareholder right to act by written consent, if properly presented at the meeting;
5.Consider and act upon a shareholder proposal regarding a government censorship transparency report, if properly presented at the meeting;
6.Consider and act upon a shareholder proposal regarding a report on respecting workforce civil liberties, if properly presented at the meeting;
7.Transact such other business as may properly come before the meeting.
|
| 2024-04-11 |
股东大会：
将于2024-05-28召开股东大会
会议内容 ▼▲
- 1.Elect the 12 Director nominees named in this proxy statement;
2.Consider and act upon a proposal to approve, by non-binding advisory vote, the compensation of our Named Executive Officers;
3.Consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2024;
4. Consider and act upon a shareholder proposal regarding a shareholder right to act by written consent, if properly presented at the meeting;
5.Consider and act upon a shareholder proposal regarding a government censorship transparency report, if properly presented at the meeting;
6.Consider and act upon a shareholder proposal regarding a report on respecting workforce civil liberties, if properly presented at the meeting;
7.Transact such other business as may properly come before the meeting.
|
| 2024-02-26 |
详情>>
业绩披露：
2023年年报每股收益0.14美元,归母净利润3.65亿美元,同比去年增长-97.49%
|
| 2023-04-03 |
股东大会：
将于2023-05-23召开股东大会
会议内容 ▼▲
- 1.Elect the 13 Director nominees named in this proxy statement;
2.Consider and act upon a proposal to approve, by non-binding advisory vote, the compensation of our Named Executive Officers;
3.Consider and act upon a proposal to approve, by non-binding advisory vote, the frequency of future votes to approve the compensation of our Named Executive Officers;
4.Consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2023;
5.Consider and act upon a shareholder proposal regarding business operations in China, if properly presented at the meeting;
6.Consider and act upon a shareholder proposal regarding access to COVID-19 products, if properly presented at the meeting;
7.Consider and act upon a shareholder proposal regarding indirect political spending, if properly presented at the meeting;
8.Consider and act upon a shareholder proposal regarding patents and access, if properly presented at the meeting;
9.Consider and act upon a shareholder proposal regarding a congruency report of partnerships with globalist organizations, if properly presented at the meeting;
10.Consider and act upon a shareholder proposal regarding an independent board chairman, if properly presented at the meeting;
11.Transact such other business as may properly come before the meeting.
|
| 2023-04-03 |
股东大会：
将于2023-05-23召开股东大会
会议内容 ▼▲
- 1.Elect the 13 Director nominees named in this proxy statement;
2.Consider and act upon a proposal to approve, by non-binding advisory vote, the compensation of our Named Executive Officers;
3.Consider and act upon a proposal to approve, by non-binding advisory vote, the frequency of future votes to approve the compensation of our Named Executive Officers;
4.Consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2023;
5.Consider and act upon a shareholder proposal regarding business operations in China, if properly presented at the meeting;
6.Consider and act upon a shareholder proposal regarding access to COVID-19 products, if properly presented at the meeting;
7.Consider and act upon a shareholder proposal regarding indirect political spending, if properly presented at the meeting;
8.Consider and act upon a shareholder proposal regarding patents and access, if properly presented at the meeting;
9.Consider and act upon a shareholder proposal regarding a congruency report of partnerships with globalist organizations, if properly presented at the meeting;
10.Consider and act upon a shareholder proposal regarding an independent board chairman, if properly presented at the meeting;
11.Transact such other business as may properly come before the meeting.
|
| 2023-04-03 |
股东大会：
将于2023-05-23召开股东大会
会议内容 ▼▲
- 1.Elect the 13 Director nominees named in this proxy statement;
2.Consider and act upon a proposal to approve, by non-binding advisory vote, the compensation of our Named Executive Officers;
3.Consider and act upon a proposal to approve, by non-binding advisory vote, the frequency of future votes to approve the compensation of our Named Executive Officers;
4.Consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2023;
5.Consider and act upon a shareholder proposal regarding business operations in China, if properly presented at the meeting;
6.Consider and act upon a shareholder proposal regarding access to COVID-19 products, if properly presented at the meeting;
7.Consider and act upon a shareholder proposal regarding indirect political spending, if properly presented at the meeting;
8.Consider and act upon a shareholder proposal regarding patents and access, if properly presented at the meeting;
9.Consider and act upon a shareholder proposal regarding a congruency report of partnerships with globalist organizations, if properly presented at the meeting;
10.Consider and act upon a shareholder proposal regarding an independent board chairman, if properly presented at the meeting;
11.Transact such other business as may properly come before the meeting.
|
| 2022-04-04 |
股东大会：
将于2022-05-24召开股东大会
会议内容 ▼▲
- 1.Elect the 14 Director nominees named in the proxy statement;
2.Consider and act upon a proposal to approve, by non-binding advisory vote, the compensation of our Named Executive Officers;
3.Consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2022;
4.Consider and act upon a shareholder proposal regarding an independent board chairman, if properly presented at the meeting;
5.Consider and act upon a shareholder proposal regarding lobbying expenditure disclosure, if properly presented at the meeting;
6.Transact such other business as may properly come before the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-05 |
股东大会：
将于2021-05-25召开股东大会
会议内容 ▼▲
- 1.Election of Directors
2.Non-binding Advisory Vote to Approve the Compensation of our Named Executive Officers(Say-on-Pay)
3.Ratification of Appointment of Independent Registered Public Accounting Firm for 2021
4.Shareholder Proposal Concerning a Shareholder Right to Act by Written Consent
5.Shareholder Proposal Regarding Access to COVID-19 Products
|
| 2020-04-06 |
股东大会：
将于2020-05-26召开股东大会
会议内容 ▼▲
- 1.Elect the 13 Director nominees named in the proxy statement;
2.Consider and act upon a proposal to approve, by non-binding advisory vote, the compensation of our Named Executive Officers;
3.Consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2020;
4.Consider and act upon a shareholder proposal concerning a shareholder right to act by written consent, if properly presented at the meeting;
5.Consider and act upon a shareholder proposal regarding allocation of corporate tax savings, if properly presented at the meeting;
6.Transact such other business as may properly come before the meeting.
|
| 2020-01-28 |
除权日：
美东时间 2020-03-13 每股派息0.61美元
|
| 2019-11-19 |
除权日：
美东时间 2019-12-13 每股派息0.61美元
|
| 2019-07-23 |
除权日：
美东时间 2019-09-13 每股派息0.55美元
|
| 2019-05-28 |
除权日：
美东时间 2019-06-14 每股派息0.55美元
|
| 2019-04-08 |
股东大会：
将于2019-05-28召开股东大会
会议内容 ▼▲
- 1.Consider and act upon a proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2019;
2.Consider and act upon a shareholder proposal concerning an independent board chairman, if properly presented at the meeting;
3.Consider and act upon a shareholder proposal concerning executive incentives and stock buybacks, if properly presented at the meeting;
4.Consider and act upon a shareholder proposal concerning drug pricing, if properly presented at the meeting;
5.Transact such other business as may properly come before the meeting.
|
| 2019-01-29 |
除权日：
美东时间 2019-03-14 每股派息0.55美元
|
| 2018-10-25 |
除权日：
美东时间 2018-12-14 每股派息0.55美元
|
| 2018-07-24 |
除权日：
美东时间 2018-09-14 每股派息0.48美元
|
| 2018-05-22 |
除权日：
美东时间 2018-06-14 每股派息0.48美元
|
| 2018-04-09 |
股东大会：
将于2018-05-22召开股东大会
会议内容 ▼▲
- 1.Election of Directors.
2.Non-binding Advisory Vote to Approve the Compensation of our Named Executive Officers (Say on Pay)
3.Ratification of Appointment of Independent Registered Public Accounting Firm for 2018
4.Shareholder Proposal
|
| 2018-01-23 |
除权日：
美东时间 2018-03-14 每股派息0.48美元
|
| 2017-11-28 |
除权日：
美东时间 2017-12-14 每股派息0.47美元
|
| 2017-07-25 |
除权日：
美东时间 2017-09-14 每股派息0.47美元
|
| 2017-05-23 |
除权日：
美东时间 2017-06-13 每股派息0.47美元
|
| 2017-04-10 |
股东大会：
将于2017-05-23召开股东大会
会议内容 ▼▲
- 1.Election of Directors.
2.Non-binding Advisory Vote to Approve the Compensation of our Named Executive Officers (Say on Pay).
3.Non-binding Advisory Vote on the Frequency of Future Votes to Approve the Compensation of our Named Executive Officers.
4.Ratification of Appointment of Independent Registered Public Accounting Firm for 2017.
5.Shareholder Proposal Concerning Independent Board Chairman.
6.Shareholder Proposal Concerning Employee Practices in Israel/Palestine.
7.Shareholder Proposal Requesting a Report on Conducting Business in Conflict-Affected Areas.
8.Shareholder Proposal Requesting a Report on Board Oversight of Product Safety and Quality.
|
| 2017-02-28 |
除权日：
美东时间 2017-03-13 每股派息0.47美元
|
| 2016-11-22 |
除权日：
美东时间 2016-12-13 每股派息0.47美元
|
| 2016-07-26 |
除权日：
美东时间 2016-09-13 每股派息0.46美元
|
| 2016-05-24 |
除权日：
美东时间 2016-06-13 每股派息0.46美元
|
| 2016-04-11 |
股东大会：
将于2016-05-24召开股东大会
会议内容 ▼▲
- 1.Election of Directors.
2.Non-binding Advisory Vote to Approve the Compensation of our Named Executive Officers (Say on Pay).
3.Ratification of Appointment of Independent Registered Public Accounting Firm for 2016.
4.Shareholder Proposal Concerning Shareholders’ Right to Act by Written Consent.
5.Shareholder Proposal Concerning Independent Board Chairman.
6.Shareholder Proposal Concerning Disposal of Unused or Expired Drugs.
|
| 2016-02-23 |
除权日：
美东时间 2016-03-11 每股派息0.46美元
|
| 2015-12-07 |
除权日：
美东时间 2015-12-11 每股派息0.46美元
|
| 2015-07-22 |
除权日：
美东时间 2015-09-11 每股派息0.45美元
|
| 2015-05-26 |
除权日：
美东时间 2015-06-11 每股派息0.45美元
|
| 2015-02-24 |
除权日：
美东时间 2015-03-12 每股派息0.45美元
|
| 2014-11-25 |
除权日：
美东时间 2014-12-11 每股派息0.45美元
|
| 2014-07-23 |
除权日：
美东时间 2014-09-11 每股派息0.44美元
|
| 2014-05-27 |
除权日：
美东时间 2014-06-12 每股派息0.44美元
|
| 2014-02-25 |
除权日：
美东时间 2014-03-13 每股派息0.44美元
|
| 2013-11-26 |
除权日：
美东时间 2013-12-12 每股派息0.44美元
|
| 2013-07-24 |
除权日：
美东时间 2013-09-12 每股派息0.43美元
|
| 2013-05-28 |
除权日：
美东时间 2013-06-13 每股派息0.43美元
|
| 2013-02-26 |
除权日：
美东时间 2013-03-13 每股派息0.43美元
|
| 2012-11-27 |
除权日：
美东时间 2012-12-13 每股派息0.43美元
|
| 2012-07-24 |
除权日：
美东时间 2012-09-13 每股派息0.42美元
|
| 2012-05-22 |
除权日：
美东时间 2012-06-13 每股派息0.42美元
|
| 2012-02-28 |
除权日：
美东时间 2012-03-13 每股派息0.42美元
|
| 2011-11-10 |
除权日：
美东时间 2011-12-13 每股派息0.42美元
|
| 2011-07-26 |
除权日：
美东时间 2011-09-13 每股派息0.38美元
|
| 2011-05-24 |
除权日：
美东时间 2011-06-13 每股派息0.38美元
|
| 2011-02-22 |
除权日：
美东时间 2011-03-11 每股派息0.38美元
|
| 2010-11-23 |
除权日：
美东时间 2010-12-13 每股派息0.38美元
|
| 2010-07-27 |
除权日：
美东时间 2010-09-13 每股派息0.38美元
|
| 2010-05-26 |
除权日：
美东时间 2010-06-11 每股派息0.38美元
|